miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a

Xiaojing Yang1, Min Feng, Xia Jiang

  • 1Cancer Biology and Pharmacology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology, and Research), Singapore 138672.

Genes & Development
|October 17, 2009
PubMed

Insights

The Rb-E2F pathway is regulated by miR-449a/b, which inhibits cell proliferation. Epigenetic repression of miR-449a/b in cancer allows uncontrolled cell growth, highlighting its tumor suppressor role.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Biology

Background:

  • The Retinoblastoma (Rb)-E2F pathway is crucial for cell cycle progression and proliferation.
  • Mechanisms maintaining Rb-E2F pathway activity are not fully elucidated.
  • Dysregulation of this pathway is implicated in human cancers.

Purpose of the Study:

  • To investigate the regulatory role of microRNAs in the Rb-E2F pathway.
  • To identify novel feedback mechanisms controlling cell cycle progression.
  • To explore the epigenetic regulation of microRNAs in cancer.

Main Methods:

  • Luciferase reporter assays to confirm E2F1-mediated transactivation of miR-449a/b.
  • Western blotting to assess protein levels of CDK6, CDC25A, and phosphorylated Rb.
  • Quantitative PCR to measure miR-449a/b expression.
  • Chromatin immunoprecipitation assays to analyze histone modifications.
  • Treatment of cancer cells with epigenetic drugs targeting histone methylation.

Main Results:

  • E2F1 directly activates the transcription of miR-449a/b.
  • miR-449a/b targets and inhibits oncogenic CDK6 and CDC25A.
  • This inhibition leads to pRb dephosphorylation and G1 cell cycle arrest, establishing negative feedback.
  • miR-449a/b expression is epigenetically silenced in cancer cells via H3K27 trimethylation.
  • Epigenetic drug treatment restores miR-449a/b expression and inhibits cell proliferation.

Conclusions:

  • miR-449a/b acts as a tumor suppressor by negatively regulating the Rb/E2F1 pathway.
  • Aberrant epigenetic silencing of miR-449a/b contributes to E2F1 deregulation in cancer.
  • Targeting epigenetic mechanisms offers a potential therapeutic strategy for cancers with deregulated E2F1 activity.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...